IRMD

SEC source: 0001950129-25-000007 · form4-12122025_051215.xml · nonDerivative · entry 1

Scharen-Guivel Hilda Frederique · CIK 0001950129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001253497-25-000015 · form4-12122025_051211.xml · derivative · entry 5

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,624

Underlying: Common Stock · 1,812 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

F3 · derivative.expiration_date: The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001253497-25-000015 · form4-12122025_051211.xml · nonDerivative · entry 4

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,460

SEC source: 0001253497-25-000015 · form4-12122025_051211.xml · nonDerivative · entry 3

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,174

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001253497-25-000015 · form4-12122025_051211.xml · nonDerivative · entry 2

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,362

SEC source: 0001253497-25-000015 · form4-12122025_051211.xml · nonDerivative · entry 1

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,894

F1 · price: This transaction was executed in multiple trades at prices ranging from $97.00 to $97.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001253352-25-000006 · form4-12122025_051209.xml · derivative · entry 2

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 906

Underlying: Common Stock · 905 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0001253352-25-000006 · form4-12122025_051209.xml · nonDerivative · entry 1

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000898243-25-000028 · form4-12152025_051203.xml · derivative · entry 1

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,932

Underlying: Common Stock · 1,026 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0001253352-25-000008 · form4-12152025_051201.xml · derivative · entry 1

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,932

Underlying: Common Stock · 1,026 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0001950129-25-000009 · form4-12152025_051205.xml · derivative · entry 1

Scharen-Guivel Hilda Frederique · CIK 0001950129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,932

Underlying: Common Stock · 1,026 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 11, 2025, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898243-25-000024 · form4-12102025_051201.xml · nonDerivative · entry 1

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,742

F1 · price: This transaction was executed in multiple trades at prices ranging from $96.50 to $97.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 4

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,297,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

SEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 3

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,297,600

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F4 · price: This transaction was executed in multiple trades at prices ranging from $97.01 to $97.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 2

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,297,726

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $96.15 to $96.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000037 · form4-12092025_051210.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,297,816

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $95.00 to $95.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898243-25-000022 · form4-12092025_051208.xml · derivative · entry 2

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898243-25-000022 · form4-12092025_051208.xml · nonDerivative · entry 1

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,742

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001950129-25-000005 · form4-12092025_051206.xml · derivative · entry 2

Scharen-Guivel Hilda Frederique · CIK 0001950129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0001950129-25-000005 · form4-12092025_051206.xml · nonDerivative · entry 1

Scharen-Guivel Hilda Frederique · CIK 0001950129 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,693

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001253352-25-000004 · form4-12092025_051204.xml · derivative · entry 2

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,197 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On December 7, 2023, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2024. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0001253352-25-000004 · form4-12092025_051204.xml · nonDerivative · entry 1

ALLEN MONTY K · CIK 0001253352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,095

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001253497-25-000010 · form4-12102025_051204.xml · derivative · entry 6

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,008 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares.

F4 · derivative.exercise_date: On December 7, 2022, the reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2022 through December 7, 2025.

F4 · derivative.expiration_date: On December 7, 2022, the reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of specified relative ranking of total shareholder return over a three-year period from December 8, 2022 through December 7, 2025.

SEC source: 0001253497-25-000010 · form4-12102025_051204.xml · derivative · entry 5

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,504 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in full on the third anniversary of the grant date, December 7, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

F3 · derivative.expiration_date: The reporting person received restricted stock units ("RSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in full on the third anniversary of the grant date, December 7, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

SEC source: 0001253497-25-000010 · form4-12102025_051204.xml · nonDerivative · entry 4

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,362

SEC source: 0001253497-25-000010 · form4-12102025_051204.xml · nonDerivative · entry 3

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,629

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares.

F2 · price: If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100%and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares.

SEC source: 0001253497-25-000010 · form4-12102025_051204.xml · nonDerivative · entry 2

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,621

SEC source: 0001253497-25-000010 · form4-12102025_051204.xml · nonDerivative · entry 1

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Restricted stock units convert into common stock on a one-for-one basis.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001613801-25-000035 · form4-12022025_041201.xml · nonDerivative · entry 2

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,302,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $92.53 to $93.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000035 · form4-12022025_041201.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,305,824

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $91.52 to $92.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000033 · form4-11242025_051103.xml · nonDerivative · entry 3

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,307,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F4 · price: This transaction was executed in multiple trades at prices ranging from $91.00 to $91.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000033 · form4-11242025_051103.xml · nonDerivative · entry 2

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,308,386

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $90.00 to $90.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000033 · form4-11242025_051103.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,311,944

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $88.99 to $89.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 6

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,545

SEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 5

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,545

SEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 4

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,545

SEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 3

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,317

SEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 2

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,417

SEC source: 0000898243-25-000018 · form4-11212025_041101.xml · nonDerivative · entry 1

HAWKINS JAMES B · CIK 0000898243 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,517

SEC source: 0001613801-25-000031 · form4-11192025_121101.xml · nonDerivative · entry 2

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,312,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $85.79 to $86.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000031 · form4-11192025_121101.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,314,316

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $84.80 to $85.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000028 · form4-11122025_041103.xml · nonDerivative · entry 2

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,317,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $85.29 to $86.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000028 · form4-11122025_041103.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,320,248

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $84.27 to $85.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001253497-25-000008 · form4-11122025_041101.xml · nonDerivative · entry 1

GLENN JOHN · CIK 0001253497 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

F1 · price: This transaction was executed in multiple trades at prices ranging from $84.25 to $85.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 6

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,322,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

SEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 5

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,322,600

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F6 · price: This transaction was executed in multiple trades at prices ranging from $83.52 to $84.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 4

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,324,218

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F5 · price: This transaction was executed in multiple trades at prices ranging from $82.58 to $83.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 3

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,325,553

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F4 · price: This transaction was executed in multiple trades at prices ranging from $81.50 to $81.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 2

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,326,453

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $80.61 to $81.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001613801-25-000026 · form4-11042025_041101.xml · nonDerivative · entry 1

Susi Roger E. · CIK 0001613801 · Director · CEO, PRESIDENT, CHAIRMAN · 10% owner

10b5-1 filing: Plan reported

Ownership: Indirect · By Phillip Susi 2008 Dynasty Trust

Disclosed balance after: 2,327,054

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $79.50 to $80.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.